Which has grown faster, HOLX or MRNA?

Over the past five years, MRNA grew revenue faster — HOLX at a 1.66% CAGR versus MRNA at 19.33%.

Is HOLX or MRNA more profitable?

HOLX runs the higher net margin — HOLX at 13.18% versus MRNA at -141.43%.

How have HOLX and MRNA total returns compared?

Over the past 5 years, HOLX delivered 7.99% and MRNA delivered -31.11% annualized total return. Past performance doesn't predict future results.

Hologic, Inc. (HOLX) vs Moderna, Inc. (MRNA)

A side-by-side comparison of Hologic, Inc. and Moderna, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 1, 2026. Differences are shown without an overall score or investment verdict.

HOLX

Hologic, Inc.

$16.97B

$76.01HealthcareAt close: Apr 7, 2026, 4:00 PM ET

MRNA

Moderna, Inc.

$21.75B

$54.82HealthcareAt close: Jul 31, 2026, 4:00 PM ET

Total return — HOLX vs MRNA

growth of $100 · dividends reinvested · last 7y

HOLX +73.1%MRNA +169.4%MRNA compounded faster

HOLX MRNA

HOLX vs MRNA: by the numbers

•MRNA is the larger company ($21.75B vs $16.97B market cap).
•HOLX is profitable (13.18% net margin) while MRNA runs a net loss (-141.43%).
•MRNA grew revenue faster over the past five years (19.33% vs 1.66% CAGR).

Metrics side by side

Valuation

Metric	HOLX	MRNA
P/E ratio	31.67	N/A
Forward P/E	17.21	N/A
P/S ratio	4.16	9.74
P/B ratio	3.27	3.21
EV / EBITDA	17.99	N/A
FCF yield	5.82%	N/A

Profitability

Metric	HOLX	MRNA
Gross margin	61.00%	55.35%
Operating margin	17.49%	-158.13%
Net margin	13.18%	-141.43%
ROE	10.37%	-46.61%
ROIC	7.35%	-29.70%

Growth (annualized)

Metric	HOLX	MRNA
Revenue CAGR (5Y)	1.66%	19.33%
EPS CAGR (5Y)	-0.96%	N/A
FCF CAGR (5Y)	4.46%	N/A
Total return CAGR (5Y)	0.84%	-31.11%

Frequently asked

Which has grown faster, HOLX or MRNA?: Over the past five years, MRNA grew revenue faster — HOLX at a 1.66% CAGR versus MRNA at 19.33%.
Is HOLX or MRNA more profitable?: HOLX runs the higher net margin — HOLX at 13.18% versus MRNA at -141.43%.
How have HOLX and MRNA total returns compared?: Over the past 5 years, HOLX delivered 7.99% and MRNA delivered -31.11% annualized total return. Past performance doesn't predict future results.

Go deeper

Full HOLX analysis Full MRNA analysis Interactive comparison tool

Dig into the metrics

Hologic P/E ratio Moderna P/E ratio Hologic dividend yield Moderna dividend yield Hologic ROE Moderna ROE Hologic operating margin Moderna operating margin Hologic revenue growth Moderna revenue growth Hologic free cash flow Moderna free cash flow

Hologic & Moderna appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 1, 2026.